Search by Drug Name or NDC

    NDC 68180-0411-09 Irbesartan 150 mg/1 Details

    Irbesartan 150 mg/1

    Irbesartan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is IRBESARTAN.

    Product Information

    NDC 68180-0411
    Product ID 68180-411_22c8bdba-6c34-485a-af89-3aafd7fd8605
    Associated GPIs 36150030000320
    GCN Sequence Number 034468
    GCN Sequence Number Description irbesartan TABLET 150 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 04749
    HICL Sequence Number 015576
    HICL Sequence Number Description IRBESARTAN
    Brand/Generic Generic
    Proprietary Name Irbesartan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Irbesartan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name IRBESARTAN
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201531
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0411-09 (68180041109)

    NDC Package Code 68180-411-09
    Billing NDC 68180041109
    Package 90 TABLET in 1 BOTTLE (68180-411-09)
    Marketing Start Date 2012-10-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14254
    Pricing Unit EA
    Effective Date 2023-12-20
    NDC Description IRBESARTAN 150 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-01-10
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis